Aug 12, 2019 8:00am EDT Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
Jul 25, 2019 7:00am EDT Tonix Pharmaceuticals Announces Issuance of U.S. Patent for the Composition and Formulation of TNX-102 SL
Jun 13, 2019 7:00am EDT Tonix Pharmaceuticals Announces Issuance of Patent in China for the Composition and Formulation of TNX-102 SL
May 30, 2019 8:00am EDT Tonix Pharmaceuticals Presented Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical Psychopharmacology
May 23, 2019 7:00am EDT Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate TNX-1300 for Cocaine Intoxication
May 22, 2019 4:19pm EDT Tonix Pharmaceuticals to Speak at the Second Chance Digital Impact Recipient Gala
